Cheminformatic Tools and Databases for Pharmacology

session 84265 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
SULFISOXAZOLE DISCONTINUED (is an active metabolite)

SULFISOXAZOLE


ATC J01EB05
ATC S01AB02

ANTIINFECTIVES
ANTIBACTERIAL
TREATMENT OF URINARY TRACT INFECTIONS
SULFONAMIDES

ORAL INJECTION OPHTHALMIC

Cmax 682 MICROMOLAR

Tmax 2.5 HOUR

VD 11 LITER (65 KILOGRAM)

PPB 92 PERCENT

Cl 1.17 LITER / HOUR (65 KILOGRAM)

HT 6.2 HOUR

DIHYDROPTEROATE SYNTHASE

BACTERIAL DIHYDROPTEROATE SYNTHASE INHIBITOR CHEMBL2364668 BACTERIAL DIHYDROPTEROATE SYNTHASE P0AC13 DIHYDROPTEROATE SYNTHASE BACTERIA ENZYME TRANSFERASEANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
SULFISOXAZOLE ACETYL DISCONTINUED (has an active metabolite)

SULFISOXAZOLE ACETYL


ATC J01EB05
ATC S01AB02

ANTIINFECTIVES
ANTIBACTERIAL
TREATMENT OF URINARY TRACT INFECTIONS
SULFONAMIDES

ORAL

SOLUBILITY PRACTICALLY INSOLUBLE IN WATER

DIHYDROPTEROATE SYNTHASE

BACTERIAL DIHYDROPTEROATE SYNTHASE INHIBITOR CHEMBL2364668 BACTERIAL DIHYDROPTEROATE SYNTHASE P0AC13 DIHYDROPTEROATE SYNTHASE BACTERIA ENZYME TRANSFERASEANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |